GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) » Definitions » Days Sales Outstanding

Fuan Pharmaceutical (Group) Co (SZSE:300194) Days Sales Outstanding : 30.89 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fuan Pharmaceutical (Group) Co Days Sales Outstanding?

Fuan Pharmaceutical (Group) Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥274 Mil. Fuan Pharmaceutical (Group) Co's Revenue for the three months ended in Mar. 2024 was ¥809 Mil. Hence, Fuan Pharmaceutical (Group) Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 30.89.

The historical rank and industry rank for Fuan Pharmaceutical (Group) Co's Days Sales Outstanding or its related term are showing as below:

SZSE:300194' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.62   Med: 44.04   Max: 53.96
Current: 40.06

During the past 13 years, Fuan Pharmaceutical (Group) Co's highest Days Sales Outstanding was 53.96. The lowest was 33.62. And the median was 44.04.

SZSE:300194's Days Sales Outstanding is ranked better than
79.12% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.68 vs SZSE:300194: 40.06

Fuan Pharmaceutical (Group) Co's Days Sales Outstanding declined from Mar. 2023 (43.47) to Mar. 2024 (30.89).


Fuan Pharmaceutical (Group) Co Days Sales Outstanding Historical Data

The historical data trend for Fuan Pharmaceutical (Group) Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuan Pharmaceutical (Group) Co Days Sales Outstanding Chart

Fuan Pharmaceutical (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.68 48.15 44.96 47.84 39.06

Fuan Pharmaceutical (Group) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.47 46.42 43.73 39.25 30.89

Competitive Comparison of Fuan Pharmaceutical (Group) Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Fuan Pharmaceutical (Group) Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuan Pharmaceutical (Group) Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuan Pharmaceutical (Group) Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Fuan Pharmaceutical (Group) Co's Days Sales Outstanding falls into.



Fuan Pharmaceutical (Group) Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Fuan Pharmaceutical (Group) Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (316.037 + 250.702) / 2 ) / 2647.753*365
=283.3695 / 2647.753*365
=39.06

Fuan Pharmaceutical (Group) Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (250.702 + 297.317) / 2 ) / 809.4*365 / 4
=274.0095 / 809.4*365 / 4
=30.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fuan Pharmaceutical (Group) Co  (SZSE:300194) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Fuan Pharmaceutical (Group) Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Fuan Pharmaceutical (Group) Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuan Pharmaceutical (Group) Co (SZSE:300194) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Huanan 1 Road, Changshou District, Chongqing, CHN, 401254
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.

Fuan Pharmaceutical (Group) Co (SZSE:300194) Headlines

No Headlines